pISSN 1976-2283
eISSN 2005-1212

Download original image
Fig. 1. Experimental design flowchart. Of the 28 volunteers who were recruited to participate, 16 met the inclusion criteria for enrollment; the other 12 exhibited abnormal electrogastrogram (EGG) responses to the water-load test. In this placebo-controlled crossover design, the enrolled participants were randomly assigned to receive either lipase or placebo during Visit 1, and the other treatment was administered during Visit 2. Visits were separated by at least 1 week.
Gut Liver 2015;9:464~469 https://doi.org/10.5009/gnl14005
© Gut and Liver